Richard Aranda
Chief Tech/Sci/R&D Officer at GOSSAMER BIO, INC.
Net worth: 234 583 $ as of 31/03/2024
Richard Aranda active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GOSSAMER BIO, INC. | Chief Tech/Sci/R&D Officer | 01/06/2021 | - |
| Corporate Officer/Principal | - | 01/06/2021 |
Career history of Richard Aranda
Former positions of Richard Aranda
| Companies | Position | Start | End |
|---|---|---|---|
| RECEPTOS INC | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
| Novo-Nordisk Biochem, Inc. | Corporate Officer/Principal | 01/01/2011 | 01/01/2015 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/08/2001 | 01/05/2011 |
Training of Richard Aranda
| University of California, Santa Cruz | Undergraduate Degree |
| Stanford School of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
| Novo-Nordisk Biochem, Inc. |
- Stock Market
- Insiders
- Richard Aranda
- Experience